Tilray Brands Inc vs Trade Desk Inc — how do they compare? Tilray Brands Inc trades at $4.21 (market cap $591.60M), while Trade Desk Inc trades at $13.92 (market cap $6.59B). The key difference: Trade Desk Inc is far larger — about 11.1× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.
| TLRY | TTD | |
|---|---|---|
Market Cap | $591.60M | $6.59B |
Sector | Health | Technology |
52-Week High | $21.00 | $54.13 |
52-Week Low | $3.88 | $13.03 |
Enterprise Value | $758.73M | $5.54B |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.
TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.
The Trade Desk (TTD) trades at $14.02, down 2.84% amid bearish technical signals and recent earnings misses. The stock faces headwinds from slowing revenue growth (3% in Q2 2026) and a 15% workforce reduction announced in September 2026. Despite solid profitability margins (net margin 13.61%) and reasonable valuation (P/E 16.69), negative cash flow trends and competitive pressures weigh on sentiment. Technical indicators show resistance at $15 with support at $13-14, while analyst consensus remains mixed with a $14.07 price target.
Outlook: TTD's long-term ad-tech positioning and AI innovations (Kokai Zuma) offer growth potential, but near-term execution risks and macro ad demand softness pose challenges. Investors should monitor Q3 earnings and restructuring efficacy for catalysts. Risks include heightened competition and reliance on digital ad spending cycles.
Trailing returns across standard periods
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →